Chapter 6

Molecular Diagnosis of Ataxias and Spastic Paraplegias

T. Gasser

T. Gasser

University of Tübingen, and German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany

Search for more papers by this author
J. Finsterer

J. Finsterer

Rudolfstiftung and Danube University, Krems, Vienna, Austria

Search for more papers by this author
J. Baets

J. Baets

University Hospital of Antwerp, Antwerpen, Belgium

VIB, Antwerpen, Belgium

Institute Born-Bunge, University of Antwerp, Antwerp, Belgium

Search for more papers by this author
C. Van Broeckhoven

C. Van Broeckhoven

VIB, Antwerpen, Belgium

Institute Born-Bunge, University of Antwerp, Antwerp, Belgium

Search for more papers by this author
S. Di Donato

S. Di Donato

Fondazione-IRCCS, Istituto Neurologico Carlo Besta, Milan, Italy

Search for more papers by this author
B. Fontaine

B. Fontaine

Assistance Publique-Hôpitaux de Paris, Centre de référence des canalopathies musculaires, Groupe Hospitalier, Pitié-Salpêtrière, Paris, France

Search for more papers by this author
P. De Jonghe

P. De Jonghe

University Hospital of Antwerp, Antwerpen, Belgium

VIB, Antwerpen, Belgium

Search for more papers by this author
A. Lossos

A. Lossos

Hadassah University Hospital, Jerusalem, Israel

Search for more papers by this author
T. Lynch

T. Lynch

Mater Misericordiae University, Beaumont & Mater Private Hospitals, Dublin, Ireland

Search for more papers by this author
C. Mariotti

C. Mariotti

IRCCS Foundation, Neurological Institute Carlo Besta, Milan, Italy

Search for more papers by this author
L. Schöls

L. Schöls

University of Tübingen, and German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany

Search for more papers by this author
A. Spinazzola

A. Spinazzola

IRCCS Foundation, Neurological Institute Carlo Besta, Milan, Italy

Search for more papers by this author
Z. Szolnoki

Z. Szolnoki

IRCCS Foundation, Neurological Institute Carlo Besta, Milan, Italy

Search for more papers by this author
S. J. Tabrizi

S. J. Tabrizi

Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London, UK

Search for more papers by this author
C. M. E. Tallaksen

C. M. E. Tallaksen

Oslo University Hospital, and Faculty of Medicine, University of Oslo, Oslo, Norway

Search for more papers by this author
M. Zeviani

M. Zeviani

IRCCS Foundation, Neurological Institute Carlo Besta, Milan, Italy

Search for more papers by this author
J-M. Burgunder

J-M. Burgunder

University of Bern, Bern, Switzerland

Search for more papers by this author
H. F. Harbo

H. F. Harbo

Oslo University Hospital, and Faculty of Medicine, University of Oslo, Oslo, Norway

Search for more papers by this author
First published: 21 September 2011

Summary

The molecular basis of an increasing number of inherited neurological diseases has been elucidated during recent years, and molecular diagnosis of these disorders is becoming a matter of clinical practice. This progress has been particularly evident in the field of the hereditary ataxias and spastic paraplegias. The EFNS guidelines attempt to provide practical help for the clinical neurologist to make appropriate use of the possibilities of molecular testing in these two complex groups of disorders. The guidelines summarize the possibilities and limitations of molecular genetic diagnosis and discuss practical issues, such as diagnostic criteria, to inform the decision whether or not a molecular diagnostic work-up should be initiated.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.